Li, Amy Y. http://orcid.org/0000-0003-4728-084X
Sedighim, Shaina http://orcid.org/0000-0002-5146-5006
Tajik, Fatemeh http://orcid.org/0000-0001-9764-2947
Khan, Aaqil M. http://orcid.org/0009-0008-4689-769X
Radhakrishnan, Vinodh K. http://orcid.org/0000-0002-6376-7925
Dayyani, Farshid http://orcid.org/0000-0002-4970-5189
Senthil, Maheswari http://orcid.org/0000-0002-0339-8558
Article History
Accepted: 25 November 2023
First Online: 26 January 2024
Declarations
:
: This is a review article. Therefore, no ethics approval was necessary.
: This is a review article. Therefore, no consent was necessary.
: FD has received research grants (to the institution) from AstraZeneca, Bristol-Myers Squibb, Merck, Genentech/Roche, Taiho, Exelixis, Trishula, Leap Therapeutics; has received a speaker honorarium from Ipsen, Exelixis, Sirtex, Astellas, and Servier; and has received a consultancy honorarium from Sirtex, Astrazeneca, and Exelixis. The other authors (AYL, SS, FT, AMK, VKR, MS) have no relevant financial or non-financial interests to disclose.